Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Frequently asked questions
What sector does Demant A/S ADR (WILYY) operate in?
Demant A/S ADR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Demant A/S ADR (WILYY) current stock price?
As of the latest data, Demant A/S ADR stock price is $27.50, with a previous close of $27.50.
What is Demant A/S ADR (WILYY) current market capitalization?
Demant A/S ADR market cap is approximately 11.60 billion.
What is Demant A/S ADR (WILYY) Earnings Per Share (EPS)?
The trailing EPS is $0.90.
What is Demant A/S ADR (WILYY) Price-to-Earnings (P/E) ratio?
Demant A/S ADR current P/E ratio is 30.56.
What is Demant A/S ADR (WILYY) EBITDA?
Demant A/S ADR EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.17 billion.
Does Demant A/S ADR (WILYY) pay dividends?
No. Demant A/S ADR does not pay a dividend.
What is Demant A/S ADR (WILYY) beta (volatility) score?
Demant A/S ADR has a beta of 0.704, indicating lower volatility than the overall market.
